These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17678803)

  • 1. Safety concerns about perisurgical epoetin treatment: should we add antiplatelet drugs to perisurgical epoetin alfa treatment?
    Basora M; Fita G; Matute P; Díaz-Ricart M
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):623-4. PubMed ID: 17678803
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa.
    Agnihotri P; Telfer M; Butt Z; Jella A; Cella D; Kozma CM; Ahuja M; Riaz S; Akamah J
    J Am Geriatr Soc; 2007 Oct; 55(10):1557-65. PubMed ID: 17697104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
    Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
    J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilisation review of epoetin alfa in cancer patients at a cancer centre in Singapore.
    Chan A; Lim LL; Tao M
    Singapore Med J; 2009 Apr; 50(4):365-70. PubMed ID: 19421679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anaemia treatment in gynaecology: use of epoetin in onco-gynaecology and gynaecological surgery].
    Kirchner V;
    Rev Med Suisse; 2005 Apr; 1(15):1041-3, 1046-7. PubMed ID: 15918284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative anemia.
    Napolitano LM
    Surg Clin North Am; 2005 Dec; 85(6):1215-27, x. PubMed ID: 16326203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epoetin trials: randomised controlled trials don't always mimic observational data.
    Roger SD; Levin A
    Nephrol Dial Transplant; 2007 Mar; 22(3):684-6. PubMed ID: 17210590
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epoetin in cancer treatment--the end of the game?].
    Wisløff F
    Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2359. PubMed ID: 17895937
    [No Abstract]   [Full Text] [Related]  

  • 10. Anemia and response to epoetin alfa: the cause of anemia matters!
    Dharmarajan TS
    J Am Geriatr Soc; 2008 Aug; 56(8):1574-5. PubMed ID: 18808607
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized, double-blind, placebo-controlled trial of epoetin alfa in men with castration-resistant prostate cancer and anemia.
    Winquist E; Julian JA; Moore MJ; Nabid A; Sathya J; Wood L; Venner P; Levine M
    J Clin Oncol; 2009 Feb; 27(4):644-6. PubMed ID: 19103725
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic research in the intensive care unit: an unmet need.
    Haas CE; Forrest A
    Crit Care Med; 2006 Jun; 34(6):1831-3. PubMed ID: 16714989
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietin (Procrit; Epogen) revisited.
    Med Lett Drugs Ther; 2001 May; 43(1104):40-1. PubMed ID: 11353925
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy.
    Schouwink JH; Codrington H; Sleeboom HP; Kerkhofs LG; Wormhoudt LW
    Eur J Cancer; 2008 Apr; 44(6):819-29. PubMed ID: 18343652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, parallel-group, open-label trial of recombinant human erythropoietin vs preoperative autologous donation in primary total joint arthroplasty: effect on postoperative vigor and handgrip strength.
    Keating EM; Callaghan JJ; Ranawat AS; Bhirangi K; Ranawat CS
    J Arthroplasty; 2007 Apr; 22(3):325-33. PubMed ID: 17400086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease, anemia, and epoetin.
    Go AS; Ayus JC
    N Engl J Med; 2007 Mar; 356(9):957; author reply 958-9. PubMed ID: 17338046
    [No Abstract]   [Full Text] [Related]  

  • 17. The first biosimilar epoetin: but how similar is it?
    Schellekens H
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):174-8. PubMed ID: 18057303
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimized pro-active management of anemia by Epoetin alpha in pre-operative chemotherapy for primary breast cancer.
    Warm M; Kates R; Dick M; Thomas A; Mallmann P; Hoopmann M; Harbeck N
    Oncol Rep; 2009 Mar; 21(3):777-85. PubMed ID: 19212639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HX575, recombinant human epoetin alfa, for the treatment of chemotherapy-associated symptomatic anaemia in patients with solid tumours.
    Weigang-Köhler K; Vetter A; Thyroff-Friesinger U
    Onkologie; 2009 Apr; 32(4):168-74. PubMed ID: 19372711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss.
    Arroliga AC; Guntupalli KK; Beaver JS; Langholff W; Marino K; Kelly K
    Crit Care Med; 2009 Apr; 37(4):1299-307. PubMed ID: 19242343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.